Alexion Pharmaceuticals CEO Ludwig Hantson's 2019 pay rises 15% to $19M
Alexion Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: March 26, 2020
Alexion Pharmaceuticals reported fiscal year 2019 executive compensation information on March 26, 2020.
In 2019, six executives at Alexion Pharmaceuticals received on average a compensation package of $7.7M, a 3% increase compared to previous year.
Average pay of disclosed executives at Alexion Pharmaceuticals
Ludwig Hantson, Chief Executive Officer, received $19M in total, which increased by 15% compared to 2018. 80% of Hantson's compensation, or $15M, was in stock awards. Hantson also received $2.4M in non-equity incentive plan, $1.3M in salary, as well as $24K in other compensation.
Paul Clancy, Chief Financial Officer, received a compensation package of $5.9M, which increased by 7% compared to previous year. 66% of the compensation package, or $3.9M, was in stock awards.
John Orloff, Executive Vice President, Head of Research and Development, earned $5.6M in 2019, a 16% increase compared to previous year.
Brian Goff, Executive Vice President, Chief Commercial and Global Operations Officer, received $5.5M in 2019, which increases by 14% compared to 2018.
Anne-Marie Law, Executive Vice President, Chief Human Experience Officer, earned $5.1M in 2019, a 3% decrease compared to previous year.
Aradhana Sarin, Chief Financial Officer, received $4.9M in 2019.
Related executives
Ludwig Hantson
Alexion Pharmaceuticals
Chief Executive Officer
Aradhana Sarin
Alexion Pharmaceuticals
Chief Financial Officer
Paul Clancy
Alexion Pharmaceuticals
Chief Financial Officer
Brian Goff
Alexion Pharmaceuticals
Executive Vice President, Chief Commercial and Global Operations Officer
Anne-Marie Law
Alexion Pharmaceuticals
Executive Vice President, Chief Human Experience Officer
John Orloff
Alexion Pharmaceuticals
Executive Vice President, Head of Research and Development
You may also like
Source: SEC filing on March 26, 2020.